Build Your Comparison

Side-by-side financial analysis
CTEV logo
CTEV
EHTH logo
EHTH
HIMS logo
HIMS
TDOC logo
TDOC
EXLS logo
EXLS
Try popular comparisons:

Stock Comparison

CTEV vs EHTH vs HIMS vs TDOC vs EXLS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CTEV
Claritev Corporation

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$502M
5Y Perf.+40.2%
EHTH
eHealth, Inc.

Insurance - Brokers

Financial ServicesNASDAQ • US
Market Cap$51M
5Y Perf.-81.3%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$7.79B
5Y Perf.-21.3%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.46B
5Y Perf.-15.6%
EXLS
ExlService Holdings, Inc.

Information Technology Services

TechnologyNASDAQ • US
Market Cap$4.06B
5Y Perf.-46.5%

CTEV vs EHTH vs HIMS vs TDOC vs EXLS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CTEV logoCTEV
EHTH logoEHTH
HIMS logoHIMS
TDOC logoTDOC
EXLS logoEXLS
IndustryMedical - Healthcare Information ServicesInsurance - BrokersMedical - Equipment & ServicesMedical - Healthcare Information ServicesInformation Technology Services
Market Cap$502M$51M$7.79B$1.46B$4.06B
Revenue (TTM)$979M$529M$2.37B$2.51B$2.16B
Net Income (TTM)$-287M$33M$-13M$-171M$252M
Gross Margin61.1%98.8%67.6%65.6%38.5%
Operating Margin4.3%12.6%1.3%-7.6%15.2%
Forward P/E69.5x11.6x
Total Debt$4.63B$134M$1.26B$1.04B$404M
Cash & Equiv.$17M$74M$229M$781M$146M

CTEV vs EHTH vs HIMS vs TDOC vs EXLSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CTEV
EHTH
HIMS
TDOC
EXLS
StockFeb 25Jun 26Return
Claritev Corporation (CTEV)100140.2+40.2%
eHealth, Inc. (EHTH)10018.7-81.3%
Hims & Hers Health,… (HIMS)10078.7-21.3%
Teladoc Health, Inc. (TDOC)10084.4-15.6%
ExlService Holdings… (EXLS)10053.5-46.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: CTEV vs EHTH vs HIMS vs TDOC vs EXLS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: EXLS leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. eHealth, Inc. is the stronger pick specifically for dividend income and shareholder returns. HIMS and TDOC also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇EXLS emerged as the overall leader. Track its performance:
CTEV
Claritev Corporation
The Healthcare Pick

Among these 5 stocks, CTEV doesn't own a clear edge in any measured category.

Best for: healthcare exposure
EHTH
eHealth, Inc.
The Insurance Pick

EHTH is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 3 yrs, beta 1.68, yield 11.7%
  • Lower volatility, beta 1.68, Low D/E 13.8%, current ratio 3.37x
  • Beta 1.68, yield 11.7%, current ratio 3.37x
  • 11.7% yield; 3-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability and sleep-well-at-night
HIMS
Hims & Hers Health, Inc.
The Growth Play

HIMS ranks third and is worth considering specifically for growth exposure and long-term compounding.

  • Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
  • 261.9% 10Y total return vs EXLS's 149.3%
  • 59.0% revenue growth vs TDOC's -1.5%
Best for: growth exposure and long-term compounding
TDOC
Teladoc Health, Inc.
The Momentum Pick

TDOC is the clearest fit if your priority is momentum.

  • +15.1% vs EHTH's -59.5%
Best for: momentum
EXLS
ExlService Holdings, Inc.
The Value Play

EXLS carries the broadest edge in this set and is the clearest fit for value and quality.

  • Lower P/E (11.6x vs 69.5x)
  • 11.7% margin vs CTEV's -29.3%
  • Beta 0.42 vs HIMS's 2.53, lower leverage
  • 14.8% ROA vs TDOC's -5.9%, ROIC 20.4% vs -11.5%
Best for: value and quality
See the full category breakdown
CategoryWinnerWhy
GrowthHIMS logoHIMS59.0% revenue growth vs TDOC's -1.5%
ValueEXLS logoEXLSLower P/E (11.6x vs 69.5x)
Quality / MarginsEXLS logoEXLS11.7% margin vs CTEV's -29.3%
Stability / SafetyEXLS logoEXLSBeta 0.42 vs HIMS's 2.53, lower leverage
DividendsEHTH logoEHTH11.7% yield; 3-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)TDOC logoTDOC+15.1% vs EHTH's -59.5%
Efficiency (ROA)EXLS logoEXLS14.8% ROA vs TDOC's -5.9%, ROIC 20.4% vs -11.5%

CTEV vs EHTH vs HIMS vs TDOC vs EXLS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the GLP-1 Stocks Theme

These companies are key players in the GLP-1 Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
CTEVClaritev Corporation
FY 2025
Network Solutions
100.0%$207M
EHTHeHealth, Inc.
FY 2025
Commission
47.3%$498M
Medicare
43.8%$461M
Product and Service, Other
5.3%$56M
Ancillaries
1.8%$19M
Small Business
1.1%$11M
Individual and Family
0.4%$4M
Commission Bonus
0.3%$3M
HIMSHims & Hers Health, Inc.

Segment breakdown not available.

TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M
EXLSExlService Holdings, Inc.
FY 2024
Digital Operations And Solutions Services
56.7%$1.0B
Analytics Services
43.3%$796M

CTEV vs EHTH vs HIMS vs TDOC vs EXLS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEHTHLAGGINGTDOC

Income & Cash Flow (Last 12 Months)

EXLS leads this category, winning 4 of 6 comparable metrics.

TDOC is the larger business by revenue, generating $2.5B annually — 4.8x EHTH's $529M. EXLS is the more profitable business, keeping 11.7% of every revenue dollar as net income compared to CTEV's -29.3%. On growth, EXLS holds the edge at +13.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
RevenueTrailing 12 months$979M$529M$2.4B$2.5B$2.2B
EBITDAEarnings before interest/tax$490M$80M$99M$42M$410M
Net IncomeAfter-tax profit-$287M$33M-$13M-$171M$252M
Free Cash FlowCash after capex-$39M-$75M$76M$251M$297M
Gross MarginGross profit ÷ Revenue+61.1%+98.8%+67.6%+65.6%+38.5%
Operating MarginEBIT ÷ Revenue+4.3%+12.6%+1.3%-7.6%+15.2%
Net MarginNet income ÷ Revenue-29.3%+6.3%-0.6%-6.8%+11.7%
FCF MarginFCF ÷ Revenue-4.0%-14.3%+3.2%+10.0%+13.8%
Rev. Growth (YoY)Latest quarter vs prior year+5.8%-22.2%+3.8%-2.5%+13.8%
EPS Growth (YoY)Latest quarter vs prior year-0.7%-72.7%-3.0%+32.1%+7.5%
EXLS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

EHTH leads this category, winning 3 of 5 comparable metrics.

At 16.8x trailing earnings, EXLS trades at a 76% valuation discount to HIMS's 69.5x P/E. On an enterprise value basis, EHTH's 1.4x EV/EBITDA is more attractive than HIMS's 55.1x.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
Market CapShares × price$502M$51M$7.8B$1.5B$4.1B
Enterprise ValueMkt cap + debt − cash$5.1B$112M$8.8B$1.7B$4.3B
Trailing P/EPrice ÷ TTM EPS-1.70x-4.85x69.55x-7.08x16.84x
Forward P/EPrice ÷ next-FY EPS est.11.60x
PEG RatioP/E ÷ EPS growth rate0.69x
EV / EBITDAEnterprise value multiple10.37x1.36x55.10x17.12x11.57x
Price / SalesMarket cap ÷ Revenue0.52x0.09x3.32x0.58x1.94x
Price / BookPrice ÷ Book value/share0.05x16.93x1.03x4.62x
Price / FCFMarket cap ÷ FCF105.30x5.10x13.60x
EHTH leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

EXLS leads this category, winning 6 of 9 comparable metrics.

EXLS delivers a 27.2% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-12 for TDOC. EHTH carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.34x. On the Piotroski fundamental quality scale (0–9), EXLS scores 7/9 vs EHTH's 2/9, reflecting strong financial health.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
ROE (TTM)Return on equity+4.0%-2.5%-12.4%+27.2%
ROA (TTM)Return on assets-5.8%+2.9%-0.6%-5.9%+14.8%
ROICReturn on invested capital+0.7%+6.1%+8.6%-11.5%+20.4%
ROCEReturn on capital employed+0.9%+6.2%+9.4%-10.0%+23.2%
Piotroski ScoreFundamental quality 0–952467
Debt / EquityFinancial leverage0.14x2.34x0.75x0.44x
Net DebtTotal debt minus cash$4.6B$61M$1.0B$259M$257M
Cash & Equiv.Liquid assets$17M$74M$229M$781M$146M
Total DebtShort + long-term debt$4.6B$134M$1.3B$1.0B$404M
Interest CoverageEBIT ÷ Interest expense0.18x5.03x-8.76x11.80x
EXLS leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HIMS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HIMS five years ago would be worth $31,955 today (with dividends reinvested), compared to $270 for EHTH. Over the past 12 months, TDOC leads with a +15.1% total return vs EHTH's -59.5%. The 3-year compound annual growth rate (CAGR) favors HIMS at 62.0% vs EHTH's -43.8% — a key indicator of consistent wealth creation.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
YTD ReturnYear-to-date-13.2%-61.3%+6.2%+14.5%-37.1%
1-Year ReturnPast 12 months-27.1%-59.5%-41.9%+15.1%-42.6%
3-Year ReturnCumulative with dividends+0.8%-82.2%+324.8%-67.6%-14.0%
5-Year ReturnCumulative with dividends+0.8%-97.3%+219.5%-94.8%+22.6%
10-Year ReturnCumulative with dividends+0.8%-88.3%+261.9%-37.7%+149.3%
CAGR (3Y)Annualised 3-year return+0.3%-43.8%+62.0%-31.3%-4.9%
HIMS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — TDOC and EXLS each lead in 1 of 2 comparable metrics.

EXLS is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than HIMS's 2.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TDOC currently trades 82.6% from its 52-week high vs EHTH's 28.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
Beta (5Y)Sensitivity to S&P 5002.26x1.68x2.53x1.82x0.42x
52-Week HighHighest price in past year$74.07$5.89$70.43$9.77$48.03
52-Week LowLowest price in past year$11.50$1.20$13.74$4.40$25.64
% of 52W HighCurrent price vs 52-week peak+39.7%+28.0%+50.4%+82.6%+54.0%
RSI (14)Momentum oscillator 0–10058.647.864.562.938.6
Avg Volume (50D)Average daily shares traded139K376K25.0M4.5M2.3M
Evenly matched — TDOC and EXLS each lead in 1 of 2 comparable metrics.

Analyst Outlook

EHTH leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CTEV as "Buy", HIMS as "Hold", TDOC as "Hold", EXLS as "Buy". Consensus price targets imply 55.2% upside for EXLS (target: $40) vs -20.8% for HIMS (target: $28). EHTH is the only dividend payer here at 11.73% yield — a key consideration for income-focused portfolios.

MetricCTEV logoCTEVClaritev Corporat…EHTH logoEHTHeHealth, Inc.HIMS logoHIMSHims & Hers Healt…TDOC logoTDOCTeladoc Health, I…EXLS logoEXLSExlService Holdin…
Analyst RatingConsensus buy/hold/sellBuyHoldHoldBuy
Price TargetConsensus 12-month target$39.25$28.08$7.40$40.25
# AnalystsCovering analysts4204219
Dividend YieldAnnual dividend ÷ price+11.7%
Dividend StreakConsecutive years of raises31
Dividend / ShareAnnual DPS$0.19
Buyback YieldShare repurchases ÷ mkt cap0.0%+4.8%+1.2%0.0%+8.1%
EHTH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

EXLS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EHTH leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OveralleHealth, Inc. (EHTH)Leads 2 of 6 categories
Loading custom metrics...

CTEV vs EHTH vs HIMS vs TDOC vs EXLS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CTEV or EHTH or HIMS or TDOC or EXLS a better buy right now?

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -1. 5% for Teladoc Health, Inc. (TDOC). ExlService Holdings, Inc. (EXLS) offers the better valuation at 16. 8x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Claritev Corporation (CTEV) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CTEV or EHTH or HIMS or TDOC or EXLS?

On trailing P/E, ExlService Holdings, Inc.

(EXLS) is the cheapest at 16. 8x versus Hims & Hers Health, Inc. at 69. 5x.

03

Which is the better long-term investment — CTEV or EHTH or HIMS or TDOC or EXLS?

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +219. 5%, compared to -97. 3% for eHealth, Inc. (EHTH). Over 10 years, the gap is even starker: HIMS returned +261. 9% versus EHTH's -88. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CTEV or EHTH or HIMS or TDOC or EXLS?

By beta (market sensitivity over 5 years), ExlService Holdings, Inc.

(EXLS) is the lower-risk stock at 0. 42β versus Hims & Hers Health, Inc. 's 2. 53β — meaning HIMS is approximately 496% more volatile than EXLS relative to the S&P 500. On balance sheet safety, eHealth, Inc. (EHTH) carries a lower debt/equity ratio of 14% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CTEV or EHTH or HIMS or TDOC or EXLS?

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -1. 5% for Teladoc Health, Inc. (TDOC). On earnings-per-share growth, the picture is similar: Claritev Corporation grew EPS 83. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CTEV or EHTH or HIMS or TDOC or EXLS?

ExlService Holdings, Inc.

(EXLS) is the more profitable company, earning 12. 0% net margin versus -29. 4% for Claritev Corporation — meaning it keeps 12. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXLS leads at 15. 0% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — EHTH leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CTEV or EHTH or HIMS or TDOC or EXLS more undervalued right now?

Analyst consensus price targets imply the most upside for EXLS: 55.

2% to $40. 25.

08

Which pays a better dividend — CTEV or EHTH or HIMS or TDOC or EXLS?

In this comparison, EHTH (11.

7% yield) pays a dividend. CTEV, HIMS, TDOC, EXLS do not pay a meaningful dividend and should not be held primarily for income.

09

Is CTEV or EHTH or HIMS or TDOC or EXLS better for a retirement portfolio?

For long-horizon retirement investors, ExlService Holdings, Inc.

(EXLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +149. 3% 10Y return). Claritev Corporation (CTEV) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EXLS: +149. 3%, CTEV: +0. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CTEV and EHTH and HIMS and TDOC and EXLS?

These companies operate in different sectors (CTEV (Healthcare) and EHTH (Financial Services) and HIMS (Healthcare) and TDOC (Healthcare) and EXLS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CTEV is a small-cap quality compounder stock; EHTH is a small-cap income-oriented stock; HIMS is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock; EXLS is a small-cap deep-value stock. EHTH pays a dividend while CTEV, HIMS, TDOC, EXLS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.